<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1230836-2AFA-4368-86D9-A704C46F5F59"><gtr:id>C1230836-2AFA-4368-86D9-A704C46F5F59</gtr:id><gtr:name>Nemaura Pharma</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1ACF2D37-682E-48E9-8C39-AECA9C57614F"><gtr:id>1ACF2D37-682E-48E9-8C39-AECA9C57614F</gtr:id><gtr:name>Immunocore Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1230836-2AFA-4368-86D9-A704C46F5F59"><gtr:id>C1230836-2AFA-4368-86D9-A704C46F5F59</gtr:id><gtr:name>Nemaura Pharma</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1ACF2D37-682E-48E9-8C39-AECA9C57614F"><gtr:id>1ACF2D37-682E-48E9-8C39-AECA9C57614F</gtr:id><gtr:name>Immunocore Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FB338F3D-5DD7-4F82-8CB9-B2B0A481647D"><gtr:id>FB338F3D-5DD7-4F82-8CB9-B2B0A481647D</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Gregory</gtr:otherNames><gtr:surname>Bligh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14132"><gtr:id>C3080F41-21F3-4408-B060-B58BD2C6F269</gtr:id><gtr:title>Bridging the academic and industry interface to satisfy unmet clinical need</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14132</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.&amp;nbsp; The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers? understanding of each other?s needs and capabilities.&amp;nbsp; This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ?entrepreneurs in residence? schemes.&amp;nbsp; Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>125000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Immunocore Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Immunocore</gtr:description><gtr:id>EEE329A9-8F85-4A6B-A93B-C31EC2E06551</gtr:id><gtr:impact>a five year &amp;pound;800,000 programme grant from Cancer Research Wales</gtr:impact><gtr:outcomeId>58c16bdea45173.32908610-1</gtr:outcomeId><gtr:partnerContribution>Fund all future consumable costs and travel expenses incurred during a follow-on programme grant, estimated to be up to &amp;pound;5k per year for five years.</gtr:partnerContribution><gtr:piContribution>support the development of a new candidate immunotherapy for colorectal cancer and further investigate the complex involvement of LAG3 in colorectal cancer progression</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nemaura Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nemaura</gtr:description><gtr:id>C839B354-8E81-475F-B028-A7EB55C8127F</gtr:id><gtr:impact>accelerate the clinical development of the mucoadhesive patches</gtr:impact><gtr:outcomeId>58c16dfedb7b79.13421490-1</gtr:outcomeId><gtr:partnerContribution>Nemaura's involvement will continue during this Life Sciences Bridging Fund project, where they have committed to provide ongoing regulatory advice to the academic team.</gtr:partnerContribution><gtr:piContribution>74,000 to continue to develop the mucoadhesive patch has been secured from the Welsh Government's Life Sciences Bridging Fund,</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>AZ Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1C62C2AE-6294-4EF2-9624-11188000943A</gtr:id><gtr:impact>a workshop, held at AstraZeneca, where researchers from Cardiff and AstraZeneca will come together to brainstorm innovative ideas for collaborative projects in the cell imaging/drug screening field. This targeted workshop has been recognised as an innovative way to encourage academia-industry interactions and will be adopted on a wider scale going forward.</gtr:impact><gtr:outcomeId>58c16b4dbe5e30.64583278</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research Wales</gtr:description><gtr:fundingOrg>Cancer Research Wales</gtr:fundingOrg><gtr:id>128223EF-19C3-469B-839C-C5ED186344DB</gtr:id><gtr:outcomeId>58c16adce80eb0.27098405</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>74000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Life Sciences Bridging Fund</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Government of Wales</gtr:fundingOrg><gtr:id>36797CD7-E452-49C8-B631-9C7D957E24C9</gtr:id><gtr:outcomeId>58c169f7360590.56876657</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Life Sciences Bridging Fund</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Government of Wales</gtr:fundingOrg><gtr:id>337AA2CD-D653-471A-9C49-54EBD88055DD</gtr:id><gtr:outcomeId>58c15d84147e68.78685293</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Life Science Bridging Fund</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Government of Wales</gtr:fundingOrg><gtr:id>0C0A09E0-83AA-41AE-A438-522EC104F19B</gtr:id><gtr:outcomeId>56c741fcd10699.41375577</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>an aid for ensuring accuracy and reproducibility of complex cell biology studies</gtr:description><gtr:id>63AAF6F6-71C1-4295-962C-DED05B02E202</gtr:id><gtr:impact>improved accuracy and reproducibility of complex cell biology studies</gtr:impact><gtr:outcomeId>58c16d15331b87.51474721</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Protocol Navigator</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.protocolnavigator.org/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14132</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>